Importantly, high expression of SPAG5 is linked to the transcriptional signature of activated YAP/TAZ in breast cancer patients, implying the involvement of YAP/TAZ in the oncogenic activity of SPAG5. The gene discussed is YAP1; the disease is breast carcinoma.